Issuer · CIK 0001974640
APGE — Apogee Therapeutics, Inc.
Recent filings
- Jun 12, 2026·Form 4·Sell$633.6K
APGE/Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS · Chief Executive Officer
38conviction - Jun 12, 2026·Form 4·Other—
APGE/Apogee Therapeutics, Inc.
Fairmount Funds Management LLC · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
APGE/Apogee Therapeutics, Inc.
Shah Nimish P · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
APGE/Apogee Therapeutics, Inc.
McKenna Mark C. · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
APGE/Apogee Therapeutics, Inc.
JONES WILLIAM A JR · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
APGE/Apogee Therapeutics, Inc.
Fox Jennifer A. · See Remarks
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
APGE/Apogee Therapeutics, Inc.
Bollinger Lisa · director
Mechanical filing
AI thesis skipped - Jun 6, 2026·Form 4·Sell$432.9K
APGE/Apogee Therapeutics, Inc.
Dambkowski Carl · director
Mechanical filing
AI thesis skipped - May 16, 2026·Form 4·Sell$1.5M
APGE/Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS · Chief Executive Officer
32conviction - May 9, 2026·Form 4·Sell$310.5K
APGE/Apogee Therapeutics, Inc.
Dambkowski Carl · director
8conviction - May 5, 2026·Form 4·Sell$74.3K
APGE/Apogee Therapeutics, Inc.
Henderson Jane · Chief Financial Officer
32conviction - Apr 17, 2026·Form 4·Sell$180K
APGE/Apogee Therapeutics, Inc.
Henderson Jane · Chief Financial Officer
32conviction